Evidence map›Paper›PMID 41359686›Full record

ArticlePLoS pathogens2025

Rare metabolic gene essentiality is a determinant of microniche adaptation in Eschherichia coli.

Omid Ardalani, Patrick V Phaneuf, Jayanth Krishnan, Siddharth M Chauhan, David Pride, Daniel C Zielinski, Jonathan M Monk, Lars K Nielsen, Bernhard O Palsson

Abstract read
In one paragraph

Article in PLoS pathogens, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Omid ArdalaniNovo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, Lyngby, Denmark.
Patrick V PhaneufNovo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, Lyngby, Denmark.
Jayanth KrishnanDepartment of Bioengineering, University of California, San Diego, La Jolla, California, United States of America.
Siddharth M ChauhanDepartment of Bioengineering, University of California, San Diego, La Jolla, California, United States of America.
David PrideDepartment of Pathology, University of California, San Diego, La Jolla, California, United States of America.
Daniel C ZielinskiDepartment of Bioengineering, University of California, San Diego, La Jolla, California, United States of America.
Jonathan M MonkDepartment of Bioengineering, University of California, San Diego, La Jolla, California, United States of America.
Lars K NielsenNovo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, Lyngby, Denmark.
Bernhard O PalssonNovo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, Lyngby, Denmark.ORCID 0000-0003-2357-6785

Funding

Novo Nordisk Foundation
6 · The paper itself

Abstract

Rare genes in bacterial pangenomes have historically been considered non-essential, dispensable, or even costly, and largely excluded from in-depth analyses due to their perceived redundancy, high variability, and presumed neutral evolutionary origin. However, whether rare genes contribute to metabolic robustness when core genes are lost remains an open question. In this study, we systematically investigate the role of rare metabolic genes in Escherichia coli, revealing their essentiality in maintaining metabolic functions under core gene loss. Through a pangenome-scale reconstruction of 15311 strain-specific genome-scale models (panGEM) and over 22.4 million gene knockout simulations, we demonstrate that: (i) 9.4% of rare metabolic genes are essential in at least one of three key host environments-feces, serum, and urine; (ii) 41% of strains rely on at least one rare essential metabolic gene for survival; (iii) rare metabolic genes emerge as a result of microniche adaptation, and (iv) panGEM allows for the prediction of a subset of highly conserved metabolic reactions with minimal genetic diversity as stable drug targets. These findings challenge the common view that rare genes primarily serve as evolutionary byproducts of genome fluidity and reveal their critical role in metabolic resilience.

Indexed as

Adaptation, PhysiologicalEscherichia coliGenes, EssentialEscherichia coli ProteinsGenome, BacterialEscherichia coli Proteins

Identifiers

PMID41359686
PMCPMC12704874

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.